• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I HBSAG QUALITATIVE II CONFIRMATORY; HBSAG CONFIRMATORY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I HBSAG QUALITATIVE II CONFIRMATORY; HBSAG CONFIRMATORY Back to Search Results
Catalog Number 08P11-22
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/09/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.Patient identifier sid's: (b)(6).This report is being filed on an international product, list number 8p11-22 that has a similar product distributed in the us, list number 8p11-21.
 
Event Description
The customer reported a false positive alinity i (b)(6) qualitative ii confirmatory result on one patient.Results provided: on (b)(6) 2020 sid (b)(6) (heparin sample) = (b)(6) = 2.06 / 1.78 / 0.91 s/co, (b)(6) = 10.05 / 10.774 / 10.929 / 10.929 s/co, sid (b)(6) (serum sample) (b)(6) confirmatory = negative, roche (b)(6) = negative, (b)(6) = 12.656 s/co; sid (b)(6) (different serum sample) (b)(6) = 12.02 s/co, (b)(6) confirmatory = positive; (b)(6) dna tagman negative.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for potential false confirmed hbsag qualitative ii results included a search for similar complaints, trending data, labeling, and device history records.A review of the result data provided by the customer was also performed.In-house testing of reagent lot 10241fn00 was completed.Return testing was not completed as returns were not available.Lot and trending review determined no trend for the issue for the product and no elevated complaint activity for the lot.Device history record review on lot 10241fn00 did not show any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.In house testing of controls which mimic patient samples was completed using retained samples of the complaint lot.All specifications were met indicating that the lot is performing acceptably.Based on the investigation, no systemic issue or deficiency of the alinity i hbsag qualitative ii confirmatory assay, lot number 10241fn00 was identified.
 
Event Description
The customer reported a false positive alinity i hbsag qualitative ii confirmatory result on one patient.Results provided: (b)(6) 2020 sid (b)(6) (heparin sample) = hbsag = 2.06 / 1.78 / 0.91 s/co, hbeag = 10.05 / 10.774 / 10.929 / 10.929 s/co, sid (b)(6) (serum sample) hbsag confirmatory = negative, roche hbsag = negative, hbeag = 12.656 s/co; sid (b)(6) (different serum sample) hbeag = 12.02 s/co, hbsag confirmatory = positive; hbv dna tagman negative.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HBSAG QUALITATIVE II CONFIRMATORY
Type of Device
HBSAG CONFIRMATORY
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key10487961
MDR Text Key233926257
Report Number3008344661-2020-00066
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 10/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/13/2020
Device Catalogue Number08P11-22
Device Lot Number10241FN00
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 08/17/2020
Initial Date FDA Received09/03/2020
Supplement Dates Manufacturer Received10/28/2020
Supplement Dates FDA Received10/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY I PROCESSING MODULE LIST 03R65-01; ALNTY I PROCESSING MODU, 03R65-01, (B)(6) ; SERIAL (B)(6)
-
-